Event Type: Maiden earnings conference call following successful listing on NSE and BSE to discuss audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.

Date and Time: The earnings conference call was held on July 17, 2026. Specific time and time zone were not disclosed in the provided transcript.

Purpose: Discussion of financial performance for the fourth quarter and financial year ended March 31, 2026, and providing investors with deeper understanding of business operations, strategy, and industry outlook.

Management Participants:

  • Dr. Nikhil Kelkar – Joint Managing Director
  • Mr. Vikram Kelkar – Managing Director
  • Mr. Soman Jana – Chief Financial Officer

Availability of Materials: The transcript of the earnings conference call is being disseminated on the company's website at www.hexagonnutrition.com. The financial results and earnings release were already circulated and available on company website and stock exchanges.

Compliance Language: The call included standard forward-looking statements disclaimer noting that actual results may differ materially from expectations due to factors beyond company's control.

Financial Period Discussed: Q4 and Financial Year 2025-26 (ended March 31, 2026)

Financial Highlights Disclosed:

  • FY26 Revenue from operations: ₹382.63 crores (17.8% YoY growth from ₹324.93 crores)
  • FY26 EBITDA: ₹52.90 crores (32.01% YoY growth)
  • FY26 EBITDA margin: 13.83% (vs 12.33% in FY25)
  • FY26 PAT: ₹37.94 crores (56.1% YoY growth from ₹24.31 crores)
  • FY26 PAT margin: 9.9% (vs 7.5% in FY25)
  • Q4 FY26 Revenue: ₹115.04 crores
  • Q4 FY26 EBITDA: ₹15.35 crores (13.34% margin)
  • Q4 FY26 PAT: ₹10.9 crores (9.5% margin)

Business Segment Breakdown:

  • Branded products: 30% of revenue (60-68% margins)
  • Premix segment: 35-40% of revenue (35-40% margins)
  • ESG segment: 30% of revenue (25-30% margins)

Capacity Utilization: Blended capacity utilization at approximately 30% (as of December YTD), with expectations to reach 35-40% range going forward.

Export Contribution: 57% of total revenues, with more than 80% of export revenue coming from premixes and ESG segments.

Geographic Exposure: Exports to West Asia constitute less than 20% of total exports.

Raw Material Sourcing: Less than 25% of total requirements imported mainly from China, Singapore, Korea, and Europe.

Additional Notes Section

The document represents a regulatory filing submitted to NSE and BSE containing the earnings call transcript. No unpublished price sensitive information was indicated to be shared during the call. The transcript included detailed management presentations covering business overview, industry landscape, financial performance, and Q&A session with analysts.